We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cathay International Holdings Ld | LSE:CTI | London | Ordinary Share | BMG1965E1030 | COM SHS $0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.75 | 0.50 | 1.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCTI
RNS Number : 6129D
Cathay International Holdings Ld
28 April 2017
Cathay International Holdings Limited
("Cathay" or the "Company")
Annual Report and Accounts
Hong Kong, 28 April 2017 - Cathay International Holdings Ltd. (LSE: CTI.L), a leading operator and investor in the growing healthcare sector in the People's Republic of China, today announces that its Annual Report and Accounts for the financial year ended 31 December 2016, together with the Notice of Annual General Meeting ("AGM"), Form of Direction and Form of Proxy for its forthcoming AGM, have been posted to shareholders.
These documents will also be uploaded to the National Storage Mechanism and will shortly be available for inspection at www.Hemscott.com/nsm. In addition, the documents will be available on the Cathay International Holdings website at http://www.cathay-intl.com.hk and may also be obtained from the Company Secretary.
The AGM will be held at the Company's Hong Kong Office at Suites 1203-4, 12/F, Li Po Chun Chambers, 189 Des Voeux Road Central, Hong Kong on 21 June 2017 at 10:00 a.m. (Hong Kong time).
For further enquiries, please contact:
Cathay International Holdings Limited Tel: +852 2828 9289 Eric Siu (Finance Director) Patrick Sung (Director and Controller) N+1 Singer Aubrey Powell / Lauren Kettle Tel: +44 (0) 20 7496 - Corporate Finance 3000 Brough Ransom - Sales Consilium Strategic Communications Tel: +44 (0) 20 3709 Mary-Jane Elliott / Matthew 5708 Neal / Lindsey Neville Cathay@consilium-comms.com
About Cathay
Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and a leading operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in the PRC and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.
The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSSEMFMWFWSESL
(END) Dow Jones Newswires
April 28, 2017 02:00 ET (06:00 GMT)
1 Year Cathay International Hol... Chart |
1 Month Cathay International Hol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions